Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stellate-ganglion block for sleep quality after breast cancer surgery
NCT02651519Phase 4Completed
- Sponsor
- China Medical University
- Start
- Jan 2016
- Primary completion
- Sep 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine in sleep deprivation, sponsored by China Medical University. Primary endpoint: Sleep quality at 1 day. Started Jan 2016; status: completed.
02
Drugs
ropivacaine
03
Conditions
sleep deprivation
Beyond the preview
Go deeper on NCT02651519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02651519.